Endostatin in the pancreas

British Journal of Cancer

Volumn 92, Issue 1, 2005, Pages 5-6

  Wigmore, S J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN;

EDITORIAL; GENE MUTATION; PANCREAS CANCER; PRIORITY JOURNAL; TISSUE HOMOGENATE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ENDOSTATINS; HUMANS; PANCREAS; PANCREATIC NEOPLASMS;

EID: 13244268319     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602180     Document Type: Editorial

References (9)

1. Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber P (2004) Endostatin's antiangiogenic signalling network. Mol Cell 13: 649-663
2. Bergers G, Jahaverian K, Lo KM, Folkman J, Hanahan D (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812
3. Brammer RD, Bramhall SR, Eggo MC (2005) Endostatin expression in pancreatic tissue is modulated by elastase. Br J Cancer 92: 89-93
4. Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, Niemela M, Ilves M, Li E, Pihlajaniemi T, Olsen BR (2002) Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J 21: 1535-1544
5. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, Fogler WE, Sim KL, Allred EN, Pirie-Shepherd SR, Folkman J (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in mouse xenograft tumor model. Cancer Res 61: 7669-7674
6. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285
7. Raut CP, Takamori RK, Davis DW, Sweeney-Gotsch B, O'Reilly MS, McConkey DJ (2004) Direct effects of recombinant human endostatin on tumor cell IL-8 production are associated with increased endothelial cell apoptosis in an orthotopic model of human pancreatic cancer. Cancer Biol Ther 3(7): Epub ahead of print
8. Schuch G, Kisker O, Atala A, Soker S (2002) Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis. Angiogenesis 5: 181-190
9. Yu Y, Moulton KS, Khan MK, Vineberg S, Boye E, Davis VM, O'Donnell PE, Bischoff J, Milstone DS (2004) E-selectin is required for the anti-angiogenic activity of endostatin. Proc Natl Acad Sci USA 101: 8005-8010